European Pharmaceutical Review

JULY 1, 2024

the CHMP gave a positive opinion for the first nasally administered emergency treatment for allergic reactions” A positive opinion was granted to the mResvia (Respiratory Syncytial Virus (RSV) mRNA vaccine). EMA’s human medicines committee decided to revoke the conditional marketing authorisation for Ocaliva. 1 virus variant.

Generic Medicine 106

Generic Medicine Vaccines Biosimilars 106

European Pharmaceutical Review

FEBRUARY 26, 2024

At its February 2024 meeting, the EMA’s human medicines committee (CHMP) recommended the extension of marketing authorisations for six treatments, and positive opinions for the approval of ten medicines. These products were designated as an orphan medicine during their development.

Generic Medicine 98

Generic Medicine Vaccines Pharmaceutical Companies Pharmaceutical Companies 98

European Pharmaceutical Review

APRIL 25, 2024

percent between 2024 and 2031. Main drivers for the market were reported to be rising popularity of generics together with blockbuster and other small-molecule drugs going off-patent globally. Overall, increasing demand for generic medicines will be a significant factor for growth. billion by 2031.

Packaging 98

Packaging Generic Medicine Diabetes Vaccines 98

Express Pharma

FEBRUARY 14, 2024

. “If accepted, these IP provisions will have drastic consequences on access to medicines and the health of patients in India and beyond. Millions of lives depend on India putting people’s health first and being able to continue supplying generic medicines globally,” according to Dr Mantoo.

Generic Medicine 103

Generic Medicine Vaccines 103

Express Pharma

JUNE 12, 2024

Covid-19 promoted India to the centre stage of global vaccine export as the consumerisation of health providing an impetus for vaccines and prompt approvals. Additionally, the Department of Pharmaceuticals, Government of India, directive requires strict compliance with the Uniform Code for Marketing Practices 2024.

Generic Medicine 105

Generic Medicine Vaccines Diabetes Immunity 105

Express Pharma

JUNE 21, 2024

Covid-19 promoted India to the centre stage of global vaccines export as consumerisation of health providing an impetus for vaccines and prompt approvals. Additionally, the Department of Pharmaceuticals, Government of India, directive requires strict compliance with the Uniform Code for Marketing Practices 2024.

Generic Medicine 102

Generic Medicine Vaccines Diabetes Immunity 102

Express Pharma

NOVEMBER 15, 2024

Integrating ESG considerations into core pharma operations India, known as the “Pharmacy of the World,” produces over 20 per cent of the global supply of generic medicines and plays a vital role in vaccine production, as per the Investindia.gov.in It meets the healthcare needs of over 1.4

Packaging 102

Packaging Generic Medicine Pharmaceutical Manufacturing Vaccines 102